Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-70
SponsorMansoura University
About this trial
We will give an anticoagulant against portal vein thrombosis, and watch for the results.
Eligibility criteria
Qualifiers
Portal vein thrombosis, Cirrhosis, With or without HCC, Child A & B
Disqualifiers
Platelets<10000, Createnine >1.9, Budd ciarri, Uncontrolled active bleeding
Trial design
Treatments tested in this trial
- Enoxaparin, warfarrin, or apixaban
Treatment groups
100 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov